Key result
Mechanism-guided management of in-stent restenosis emphasizes intracoronary imaging and tailored treatments like drug-coated balloons.
Why the study?
Coronary in-stent restenosis remains a major cause of repeat revascularisation despite advances in drug-eluting stent technology, requiring a mechanism-guided approach to treatment selection.
Design
Narrative review
Authors
Loading...
Supports mechanism-guided ISR management in practice; extends 2023-2024 classifications and guidelines with updated synthesis.
This review provides a contemporary, mechanism-guided framework for managing coronary in-stent restenosis, emphasizing intracoronary imaging and tailored therapies like drug-coated balloons and repeat stenting.
Salim et al. (2026) conducted a review in Coronary in-stent restenosis (ISR). Mechanism-guided management strategies was evaluated. This narrative review outlines a mechanism-guided approach to managing coronary in-stent restenosis, emphasizing intracoronary imaging and tailored treatments like drug-coated balloons and repeat DES.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: